O Shaughnessy Asset Management LLC lessened its holdings in Humana Inc. (NYSE:HUM – Free Report) by 56.1% during the 1st quarter, Holdings Channel reports. The firm owned 8,204 shares of the insurance provider’s stock after selling 10,485 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Humana were worth $2,845,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently modified their holdings of the company. Rakuten Securities Inc. purchased a new stake in shares of Humana in the fourth quarter valued at about $25,000. Gradient Investments LLC lifted its stake in shares of Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after buying an additional 40 shares during the period. Cetera Trust Company N.A purchased a new position in shares of Humana during the fourth quarter valued at approximately $28,000. Private Wealth Management Group LLC purchased a new position in shares of Humana during the fourth quarter valued at approximately $32,000. Finally, Carolinas Wealth Consulting LLC lifted its stake in shares of Humana by 274.1% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after buying an additional 74 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Humana Stock Up 0.1 %
NYSE HUM traded up $0.43 during trading hours on Wednesday, reaching $386.30. 860,030 shares of the company traded hands, compared to its average volume of 1,746,547. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $46.55 billion, a PE ratio of 24.13, a PEG ratio of 2.23 and a beta of 0.51. The company has a 50 day moving average of $363.52 and a two-hundred day moving average of $347.00.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on HUM shares. Truist Financial upped their price objective on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research note on Monday, July 15th. Wells Fargo & Company reduced their price objective on shares of Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Barclays reduced their price objective on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. UBS Group reduced their price objective on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research note on Thursday, April 25th. Finally, Baird R W raised shares of Humana to a “hold” rating in a research report on Thursday, May 30th. Fourteen analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $402.60.
Get Our Latest Analysis on Humana
About Humana
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More
- Five stocks we like better than Humana
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Food Processing Company Stock Gets Fried by Recall: Time to Buy
- What Are Growth Stocks and Investing in Them
- Entertainment Stock Offers A Rare and Tempting Entry Opportunity
- How to Calculate Options Profits
- Will China’s Interest Rate Cuts Ignite a Rally for This Stock?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.